CHPA introduces OTC Academy
WASHINGTON – The Consumer Healthcare Products Association on Tuesday officially launched OTC Academy, a new educational brand for the association and a go-to source for professional education on the consumer healthcare industry. Designed to expand the knowledge of industry professionals, OTC Academy will provide a comprehensive overview of business-critical topics through three different learning formats, including e-learning, seminars and workshops.
“We are thrilled to introduce OTC Academy on behalf of our member companies to enhance education on industry trends, challenges and opportunities,” stated Scott Melville, president and CEO of CHPA. “We will be leveraging our membership to identify topics and serve as a faculty of content experts to conduct timely and relevant educational programming. The Academy’s curriculum will constantly evolve and allow industry professionals to stay up-to-date on relevant industry topics such as compliance, product quality, legal, policy and sales and marketing, while providing them with resources to thrive in today’s marketplace.”
OTC Academy was created for industry professionals who seek to learn more on key topics and regulatory issues. The programs will be tailored for three levels of experience, including:
Basic – For professionals who are new to the industry and want to learn general information and best practices or for those in the industry looking for a refresher on the basics;Intermediate – For professionals with 3-5 years of experience looking to obtain a deeper understanding about specific topics; andAdvanced – For professionals with 10-plus years of experience who wish to further their expertise on a niche topic.
“The launch of OTC Academy is a helpful new offering for the consumer healthcare industry,” continued Melville. “By providing both new and seasoned industry professionals with important information on key topics related to OTC medicines, CHPA and its member companies will be better able to meet the healthcare needs of consumers while also developing new skills and insights to grow their businesses.”
The first OTC Academy seminar, “OTC 101,” will take place Oct. 14-15, 2015, in New Brunswick, N.J., and will provide a background overview of the OTC medicine and dietary supplements industries.
Wojo Nutritionals launches line of liquid supplements
OVERLAND PARK, Kan. — Wojo Nutritionals recently launched a line of single-serve liquid supplements that can be added to any drink.
Each single serving formula begins with a base of six B vitamins. It's then enhanced with a blend of herbal extracts and naturally derived amino acids and vitamins specific to its intended use. As an added health benefit, all Wojo offerings are free of sugar, artificial sweeteners and flavorings, and chemical masking agents.
Currently, there are two products available for purchase. wojoENERGY provides energy while wojoCALM is a soothing way to remove stress. This summer they'll be releasing four new offerings including wojoFOCUS, wojoSUN, wojoWELL and wojoMOOD.
GSK and WebMD join on headache education
PARSIPPANY, N.J. – To kick-off National Headache Month, GlaxoSmithKline and WebMD launched web tools aimed at educating headache sufferers on the condition and, more importantly, how to manage head pain, with new tools and engaging content.
"Here's a situation where the whole is greater than the sum of its parts. By coupling the headache expertise that the makers of Excedrin offer with the timely and trusted health information provided by WebMD, we now have an even more robust offering for headache sufferers everywhere," said Jason Milligan, senior brand manager, Excedrin.
"Millions of consumers turn to WebMD each month to find information about managing headaches and migraines," said Michael Smith, chief medical editor, WebMD. "Both WebMD and the makers of Excedrin have a shared goal of helping consumers to better understand their headache symptoms so they can make more informed decisions about treatment options."
An element of the collaboration includes a survey conducted by WebMD, which shows significant differences between what headache sufferers are doing to treat their pain and what doctors recommend. Findings from the new WebMD survey show that one out of three respondents reports suffering from headaches weekly. According to the survey, 46% of respondents choose to "tough out" their headaches, despite doctor advice. In fact, nine out of 10 physicians suggest not toughing out headaches and eight out of 10 suggest treating headaches early, because there is support for the idea that medications work better when taken at the first sign of a headache.
In addition to key insights from the survey, the following resources are now available:
- To help headache and migraine sufferers easily understand which Excedrin product is right for them, the makers of Excedrin developed a Product Selector Tool, available on Excedrin.com. The tool includes a short quiz to help identify the user's symptoms and provides a product recommendation that best suits their needs;
- Consumers and healthcare professionals will also have access to headache-related content and tools developed by WebMD's editorial team on WebMD.com/headaches and Medscape.com. These destinations will feature news and articles related to mild to moderate, tension, cluster and migraine headaches and slideshows that depict surprising headache triggers; and
- Consumers can access the WebMD Headache Assessments tool, which helps consumer analyze headaches they may experience, and the WebMD Headache Map, which provides content related to possible headache types based on the headache location and frequency.
Loading Post Please Wait...